Bliss GVS Pharma
1984
FOUNDED
PUBLIC
STATUS
401-500
EMPLOYEES
506197
STOCK SYMBOL
1
INVESTMENTS
$2.57
SHARE PRICE
(As of Tuesday Closing)
Description
Manufacturer of pharmaceutical formulations intended to improve accessibility and quality of life globally. The company's pessaries, tablets, effervescent tablets, capsules, gelatin capsules helps its customers with high quality pharmaceutical formulations at affordable prices for the global market.
Primary Industry
Drug Delivery
Stock Exchange
BOM
Primary Office
- 102, Hyde Park
- Saki Vihar Road, Andheri (East)
- Mumbai, 400072
- India
+91 022 0000 0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Bliss GVS Pharma’s full profile, request a free trial.
Bliss GVS Pharma Stock Performance
| 52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
|---|---|---|---|---|---|
| $2.39 - $3.36 | $260M | $2.58 | $0.09 | 57.9K | 103M |
Bliss GVS Pharma Financials Summary
|
In Thousands,
USD |
TTM
31-Mar-2018
|
FY 2018
31-Mar-2018
|
FY 2017
31-Mar-2017
|
FY 2016
31-Mar-2016
|
|---|---|---|---|---|
| Enterprise Value | 309,902 | 325,540 | 296,205 | 205,296 |
| Revenue | 57,704 | 57,704 | 60,132 | 83,567 |
| EBITDA | 12,667 | 12,667 | 18,144 | 26,258 |
| Net Income | 9,118 | 9,118 | 12,232 | 12,604 |
| Total Assets | 132,101 | 132,101 | 152,054 | 114,724 |
| Total Debt | 17,137 | 17,137 | 28,844 | 15,115 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Bliss GVS Pharma Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000000 000000 | 28-Jun-2012 | 000000000000000000 | Drug Delivery |
Bliss GVS Pharma Subsidiaries (1)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| 00000000 000000 | Drug Delivery | Thane, India | 0000 |